M&A Deal Summary

Anjac Acquires Pillar5 Pharma

On March 14, 2022, Anjac acquired consumer products company Pillar5 Pharma

Acquisition Highlights
  • This is Anjac’s 1st transaction in the Consumer Products sector.
  • This is Anjac’s 1st transaction in Canada.
  • This is Anjac’s 1st transaction in Ontario.

M&A Deal Summary
Date 2022-03-14
Target Pillar5 Pharma
Sector Consumer Products
Buyer(s) Anjac
Deal Type Add-on Acquisition

Target

Pillar5 Pharma

Arnprior, Ontario, Canada
Pillar5 Pharma is a Canadian CDMO with strong capabilities in sterile ophthalmic manufacturing. The company is currently the only CDMO with the ability to manufacture multi-dose preservative-free (MDPF) solutions for the North American market. Its manufacturing facility was built by Pfizer in 1956 and has been instrumental to the company’s continued growth and success. Pillar5 Pharma was formed in 2009 and is based in Arnprior, Ontario.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Anjac

Paris, France
Category Company
Founded 2008
Sector Consumer Products
DESCRIPTION

Anjac is a French family-owned industrial group and a partner to beauty & wellness brands and pharmaceutical laboratories. It creates, develops, and manufactures, from raw materials to the finished product. ANJAC is made up of the following 14 specialized and complementary companies, with 22 R&D and production sites in the fields of health, beauty, personal care and food supplements: Aircos, Apollo, Chemineau, Cosmetix West, Euro Wipes, Feltor, Innovi, LPEV, Pascual Cosmétiques, Pillar5, Roval Cosmétiques, Shadeline and Sicaf. Anjac was founded in 2008 and is based in Paris.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal